Safety of Trasylol Questioned by Doctors from Duke

By March 6, 2008Drug Safety

The Safety of Trasylol was put at issue by Doctors from Duke University Medical Center who played high-profile roles in the debate over the safety of the anti-bleeding drug Trasylol, Pharmalot notes.
Duke’s chief of thoracic and cardiovascular surgery, Dr. Peter Smith, is a consultant for Bayer AG, the company that makes Trasylol. Last fall, Smith appeared before an FDA advisory committee and testified that the drug is safe and effective.
However, 11 of Smith’s colleagues who work in the anesthesiology and surgery departments co-authored the recent study that concluded patients given Trasylol were 2.5 times more likely to die than those given a rival drug.
The lawyers of Carey, Danis & Lowe are experienced in helping people injured by a dangerous prescription drug. We will seek compensation for past and future medical expenses, past and future wages, pain and suffering, disability and other damages. We also represent family members in wrongful death cases.
We offer a free initial consultation for victims of dangerous medications. If you cannot make it to our office, we will come to you at the hospital or your home.
Contact the lawyers at Carey, Danis & Lowe today by calling 877-678-3400.